Baldwin Wealth Partners LLC MA Buys 50,862 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Baldwin Wealth Partners LLC MA increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 44.7% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 164,581 shares of the medical device company's stock after purchasing an additional 50,862 shares during the period. Baldwin Wealth Partners LLC MA owned 0.08% of Cooper Companies worth $13,882,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of COO. Covestor Ltd lifted its position in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after acquiring an additional 120 shares during the last quarter. Shell Asset Management Co. raised its position in shares of Cooper Companies by 15.5% in the fourth quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock valued at $87,000 after buying an additional 127 shares in the last quarter. UMB Bank n.a. raised its position in shares of Cooper Companies by 16.7% in the first quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock valued at $76,000 after buying an additional 129 shares in the last quarter. Torray Investment Partners LLC raised its position in shares of Cooper Companies by 0.8% in the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock valued at $1,488,000 after buying an additional 132 shares in the last quarter. Finally, Buckhead Capital Management LLC raised its position in shares of Cooper Companies by 0.3% in the fourth quarter. Buckhead Capital Management LLC now owns 48,120 shares of the medical device company's stock valued at $4,424,000 after buying an additional 152 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on COO shares. Piper Sandler reiterated an "overweight" rating and issued a $105.00 price target (down from $115.00) on shares of Cooper Companies in a research report on Friday, May 30th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $76.00 price target (down from $110.00) on shares of Cooper Companies in a research report on Friday, May 30th. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Citigroup dropped their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Finally, Robert W. Baird dropped their price target on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research report on Friday, May 30th. Five equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of "Moderate Buy" and an average target price of $100.38.

Cooper Companies Stock Performance

COO traded down $1.27 on Wednesday, hitting $71.42. The company's stock had a trading volume of 2,293,889 shares, compared to its average volume of 1,602,790. The company's 50 day simple moving average is $78.01 and its 200-day simple moving average is $86.81. The firm has a market cap of $14.28 billion, a P/E ratio of 36.63, a price-to-earnings-growth ratio of 2.25 and a beta of 0.98. The Cooper Companies, Inc. has a 12 month low of $65.00 and a 12 month high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.93 by $0.03. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. During the same period last year, the firm earned $0.85 EPS. The business's quarterly revenue was up 6.3% compared to the same quarter last year. Analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.